| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/09/2005 | CA2557508A1 Compositions and methods for the systemic treatment of arthritis |
| 09/09/2005 | CA2557499A1 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 09/09/2005 | CA2557482A1 Target for b-cell disorders |
| 09/09/2005 | CA2557093A1 Cancerous disease modifying antibodies |
| 09/09/2005 | CA2557091A1 Cancerous disease modifying antibodies |
| 09/09/2005 | CA2556632A1 Egf receptor epitope peptides and uses thereof |
| 09/09/2005 | CA2556436A1 Process for preparing anit-a.beta. antibody |
| 09/09/2005 | CA2556025A1 Method of treating abnormal cell growth using c-met and m-tor inhibitors |
| 09/09/2005 | CA2556022A1 Protein phosphorylation in t-cell receptor signaling pathways |
| 09/09/2005 | CA2556021A1 Protein phosphorylation in anaplastic large cell lymphoma |
| 09/09/2005 | CA2556019A1 Protein phosphorylation in c-src signaling pathways |
| 09/09/2005 | CA2555413A1 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof |
| 09/09/2005 | CA2555251A1 E.coli o157:h7 c1-1nh-binding protein and methods of use |
| 09/09/2005 | CA2552823A1 Antibody purification |
| 09/09/2005 | CA2552351A1 Method for determination and quantification of radiation or genotoxin exposure |
| 09/09/2005 | CA2543888A1 Monomethylvaline compounds capable of conjugation to ligands |
| 09/09/2005 | CA2497087A1 Novel genes encoding proteins involved in proanthocyanidin synthesis |
| 09/08/2005 | US20050198707 Expression vector comprisig nucleotide sequences coding arsenate reductase for use in detoxification of metal ions in soil; bioremediation |
| 09/08/2005 | US20050198695 Nematode ATP synthase subunit E-like sequences |
| 09/08/2005 | US20050197497 Used to improve the therapeutic efficacy of current cancer treatment; sensitizing cancerous cells to treatment with conventional anti-tumor drugs |
| 09/08/2005 | US20050197494 Methods of treating thrombotic diseases with von willebrand factor specific antibodies |
| 09/08/2005 | US20050197310 TGaseII polypeptide antibodies; pulmonary, kidney, liver or ocular fibrosis; cardiac hypertrophy, atherosclerosis, restenosis; Alzheimer's and Parkinson's disease |
| 09/08/2005 | US20050197295 Modified annexin proteins and methods for preventing thrombosis |
| 09/08/2005 | US20050197293 Use of an IL-1 antagonist for treating arthritis |
| 09/08/2005 | US20050196844 Antibodies to phosphorylated tau, methods of making and methods of use |
| 09/08/2005 | US20050196840 Glucose transport proteins for use in identifying modulators which prevent glucose uptake; diabetes diagnostic and therapeutic |
| 09/08/2005 | US20050196838 Reduced immunogenicity; increased affinity and avidity; improved cell culturing |
| 09/08/2005 | US20050196833 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
| 09/08/2005 | US20050196832 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/08/2005 | US20050196829 identifying polymorphisms in gene sequences coding Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A); identifying modulator for prevention and treatment of allergic disorders |
| 09/08/2005 | US20050196818 Antibodies to alpha-synuclein |
| 09/08/2005 | US20050196816 Monoclonal antibodies for binding immunoglobins |
| 09/08/2005 | US20050196815 Method for detecting protein |
| 09/08/2005 | US20050196802 peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily; use drug screening |
| 09/08/2005 | US20050196797 PI-3-kinase-related kinase polypeptide for use as tool in identifying modulators for prevntion and treatment of cell proliferation disorders |
| 09/08/2005 | US20050196783 Nucleotide sequences coding r-ounidabout (robo) regulatory protein (SLIT polypeptides) for use in treatment and prevention of nervous system disorders; nerve cell function modulators |
| 09/08/2005 | US20050196759 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 09/08/2005 | US20050196755 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 09/08/2005 | US20050196752 Genomic sequence of the 5-Lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma |
| 09/08/2005 | US20050196749 Novel nucleic acid molecules; immunospecifically binding respiratory syncytial virus (RSV) antigens; long half life; reduced dosage and side effects |
| 09/08/2005 | US20050196400 Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
| 09/08/2005 | US20050196399 antibody capable of specifically recognizing two regions of the A4 peptide/A beta 4, wherein the first region comprises the amino acid sequence AEFRHDSGY and the second region comprises the amino acid sequence YEVHHQKLVFFAEDVG |
| 09/08/2005 | US20050196397 Factor IX/factor IXa activating antibodies and antibody derivatives |
| 09/08/2005 | US20050196396 cancer therapy utilizing novel vascular endothelial cell growth factor receptor antagonists; immunoglobulin like domain from kinase domain receptor; nucleic acid encoding prolactin receptor antagonizing domain, a VEGF ligand and a cytokine; cell based assay; |
| 09/08/2005 | US20050196395 Methods of modulating immunity |
| 09/08/2005 | US20050196394 Monoclonal antibodies as well as homologues, analogues, and modified and derived forms thereof, immunoglobin fab fragments, single chain antibodies; treating pathological inflammation and autoimmune diseases |
| 09/08/2005 | US20050196390 Detecting metalloproteinase inhibitor in sample of tissue, serum, urine, tumor; detectable label is a monoclonal antibody; radioimmunoassay, enzyme linked immunoassay |
| 09/07/2005 | EP1571450A2 Cartilage Resorption assays |
| 09/07/2005 | EP1571216A2 Phosphodiesterase 8A |
| 09/07/2005 | EP1571211A1 Antibodies against lesion tissue |
| 09/07/2005 | EP1571160A1 Kit for assaying human low-molecular weight cd14 and antibody |
| 09/07/2005 | EP1570858A1 Monovalent ligand of the FCalphaRi receptor as an anti-inflammatory agent |
| 09/07/2005 | EP1570857A1 Method for inhibiting the transendothelal migration of cells such as leukocytes or tumor cells by a CD81 binding agent and uses thereof |
| 09/07/2005 | EP1570272A2 Identification of agonistic autoantibodies |
| 09/07/2005 | EP1570267A1 Assay for identifying antibody producing cells |
| 09/07/2005 | EP1570057A2 Autocrine growth factor receptor antibodies and methods |
| 09/07/2005 | EP1570053A2 Methods and apparatus for whole cell panning |
| 09/07/2005 | EP1569950A2 Plasmodium falciparum antigens and methods of use |
| 09/07/2005 | EP1569691A2 Delivery of pharmaceutical agents via the human insulin receptor |
| 09/07/2005 | EP1569689A2 Combination il2/anti-her2-antibody therapy for cancers characterized by overexpression of the her2 receptor protein |
| 09/07/2005 | EP1569688A1 Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies |
| 09/07/2005 | EP1569685A2 Complement receptor 2 targeted complement modulators |
| 09/07/2005 | EP1569675A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 09/07/2005 | EP1025237B1 Human checkpoint kinase, hcds1, compositions and methods |
| 09/07/2005 | EP0851030B1 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO |
| 09/07/2005 | CN1665926A Human IgM antibody lysing activated lymphocytes under mediation by homologous complement |
| 09/07/2005 | CN1665842A Human IgM antibody inducing apoptosis in HIV-infected cells and remedy for HIV-infection |
| 09/07/2005 | CN1665841A Method of detecting perilymphatic fistula |
| 09/07/2005 | CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 09/07/2005 | CN1665532A Calicheamicin derivative-carrier conjugates |
| 09/07/2005 | CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665391A Methods of expressing LIM mineralization protein in non-osseous cells |
| 09/07/2005 | CN1664107A DNA sequence coding for an a. thaliana protein with delta-5, 7-sterol-delta-7-reductase, the protein, process for the production, transformed yeast-strains and use |
| 09/07/2005 | CN1664100A Human antibody heavy chain and light chain variable region gene against SARS-Cov S antigen and polypeptide and use thereof |
| 09/07/2005 | CN1664095A EPSP synthase of variable halomonas high resistance glyphosate and its encoding sequence |
| 09/07/2005 | CN1663963A Hybrid interferon compositions and methods of use |
| 09/07/2005 | CN1218182C Method for separating cells using immunorosettes |
| 09/07/2005 | CN1217956C Soluble single-chain T-cell receptor proteins |
| 09/06/2005 | US6939959 Efficient protein expression system |
| 09/06/2005 | US6939956 Variable region of the monoclonal antibody against HBV S-surface antigen and a gene encoding the same |
| 09/06/2005 | US6939954 Isolated bovine lgG heavy chain protein and its use as an antimicrobial |
| 09/06/2005 | US6939851 Serine proteinase inhibitors |
| 09/06/2005 | US6939677 useful for detection, diagnosis, and treatment of breast cancer; Human milk fat globule ( HMFG) |
| 09/06/2005 | US6939547 Specific binding agents for KSHV vIL-6 that neutralize a biological activity |
| 09/06/2005 | US6939545 Composition and method for treating inflammatory disorders |
| 09/06/2005 | US6939543 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 09/06/2005 | US6938354 Measurement marking, scribing and scoring device |
| 09/06/2005 | CA2250693C Compositions and methods for taxol biosynthesis |
| 09/06/2005 | CA2105652C Reducing wound scarring with antibodies to growth factors |
| 09/03/2005 | CA2457303A1 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 09/01/2005 | WO2005080986A1 Antibodies to phosphorylated tau, methods of making and methods of use |
| 09/01/2005 | WO2005080972A1 Use of tweak modulators and inhibitors for the treatment of neurological conditions |
| 09/01/2005 | WO2005080575A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
| 09/01/2005 | WO2005080564A1 Anti-human pca-1 antibody |
| 09/01/2005 | WO2005080555A1 Monoclonal antibody specific to cell surface protein of human embroyonic stem cell |
| 09/01/2005 | WO2005080437A1 Composition for treating pathology associated with msrv/herv-w |
| 09/01/2005 | WO2005080436A2 Antibodies that bind pote and uses thereof |
| 09/01/2005 | WO2005080435A1 Monoclonal antibody and use thereof |
| 09/01/2005 | WO2005080434A1 Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits |